Frankfurt - Delayed Quote EUR
United Therapeutics Corporation (UTH.F)
276.10
+2.50
+(0.91%)
As of 8:00:43 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,411,800
1,327,100
978,000
802,500
598,200
Investing Cash Flow
-482,800
417,200
-719,600
-811,500
-486,900
Financing Cash Flow
-280,600
-1,254,800
-11,900
75,400
44,800
End Cash Position
1,899,900
1,697,200
1,207,700
961,200
894,800
Income Tax Paid Supplemental Data
396,400
400,600
332,500
275,700
153,300
Interest Paid Supplemental Data
33,000
40,200
56,000
29,100
16,200
Capital Expenditure
-283,200
-246,500
-230,400
-138,800
-120,800
Issuance of Debt
--
0
0
800,000
0
Repayment of Debt
-400,000
-400,000
-100,000
-800,000
0
Repurchase of Capital Stock
-12,200
-1,012,200
-13,800
-11,400
-10,800
Free Cash Flow
1,128,600
1,080,600
747,600
663,700
477,400
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade